ACTIVE

ISTAR MEDICAL

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-21 M €+19,3 %over 1 year
Revenue1,8 M €-3,7 %over 1 year
Equity-23,5 M €-180,8 %over 1 year
Workforce21,9 ETP-20,7 %over 1 year

Identity

Source · BCE/KBO

ISTAR MEDICAL is a Public limited company incorporated in 2010. Its main activity is: Manufacture of medical and dental instruments and supplies. Its registered office is in Wavre. It employs on average 21,9 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0828.058.712
Incorporation
20/07/2010
Legal form
Public limited company
Registered office
Avenue Sabin 6
1300 Wavre · WallonieSee on map
Contributed capital
87 955 650,05 €
Latest accounts
31/12/2025
Average workforce
21,9 ETP
Joint committees (2)
  • 200
  • 218
Signals
Healthy social debtsHigh revenue

Financials

Source · NBB, 15 filings

Trend over 11 financial years

20252024201920182017
Income statement
Revenue1,8 M €1,9 M €–7,9 k €20,7 k €
EBITDA-14,5 M €-20,1 M €-6,4 M €-5,7 M €-4,7 M €
Operating result-18 M €-25,6 M €-7,4 M €-6,5 M €-5,3 M €
Net result-21 M €-26 M €-6,2 M €-6,3 M €-5 M €
Balance sheet
Equity-23,5 M €-8,4 M €16 M €-3 M €2,7 M €
Total assets15,6 M €31 M €19,5 M €4,3 M €4,9 M €
Cash3,1 M €4 M €14,6 M €1,9 M €3,1 M €
Debts39,1 M €39,1 M €3,5 M €7,1 M €2,2 M €
Other
Workforce21,9 ETP27,6 ETP10,9 ETP8,1 ETP9,2 ETP

Board of directors

Source · NBB, accounts to 31/12/2025

5 active · 36 ended

Active mandates

Richard Beckman

Director · since 16 avril 2024 · until 30 juillet 2027

Active
Bruno Holthof

Director · since 31 juillet 2023 · until 30 juillet 2027

Active
CAPRICORN HEALTH-TECH FUND

Director · since 31 juillet 2023 · until 30 juillet 2027 · 0823.483.676

Represented by Filip Pintelon

Active
Marc Nolet de Brauwere van Steenland

Director · since 31 juillet 2023 · until 30 juillet 2027

Active
MV Lifesciences

Managing director · since 31 juillet 2023 · until 30 juillet 2027 · 0781.705.776

Represented by Michel Vanbrabant

Active

Ended mandates

Richard Beckman

Director · since 16 avril 2024 · until 31 juillet 2027

Ended
David Guyer

Chairman of the board of directors · since 26 janvier 2024 · until 30 juillet 2027

Ended
Bram Vanparys

Director · since 31 juillet 2023 · until 30 juillet 2027

Ended
Lionel Carnot

Director · since 31 juillet 2023 · until 30 juillet 2027

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date23/07/202624/09/202509/08/202405/09/202327/07/202206/07/2021
General meeting14/07/202610/09/202525/07/202402/06/202315/06/202204/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 15 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202514/07/202623/07/2026FrenchPDF
Full model31/12/202410/09/202524/09/2025FrenchPDF
Full model31/12/202325/07/202409/08/2024FrenchPDF
Full model31/12/202202/06/202305/09/2023FrenchPDF
Full model31/12/202115/06/202227/07/2022FrenchPDF
Full model31/12/202004/06/202106/07/2021FrenchPDF
Full model31/12/201905/06/202022/07/2020FrenchPDF
Full model31/12/201807/06/201920/06/2019FrenchPDF
Full model31/12/201701/06/201821/06/2018FrenchPDF
Full model31/12/201602/06/201726/07/2017FrenchPDF
Full model31/12/201503/06/201625/07/2016FrenchPDF
Full model31/12/201411/06/201503/07/2015FrenchPDF
Full model31/12/201316/07/201413/08/2014FrenchPDF
Full model31/12/201207/06/201329/08/2013FrenchPDF
Full model31/12/201101/06/201229/06/2012FrenchPDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

5 active · 36 ended

Active mandates

Richard Beckman

Director · since 16 avril 2024 · until 30 juillet 2027

Active
Bruno Holthof

Director · since 31 juillet 2023 · until 30 juillet 2027

Active
CAPRICORN HEALTH-TECH FUND

Director · since 31 juillet 2023 · until 30 juillet 2027 · 0823.483.676

Represented by Filip Pintelon

Active
Marc Nolet de Brauwere van Steenland

Director · since 31 juillet 2023 · until 30 juillet 2027

Active
MV Lifesciences

Managing director · since 31 juillet 2023 · until 30 juillet 2027 · 0781.705.776

Represented by Michel Vanbrabant

Active

Ended mandates

Richard Beckman

Director · since 16 avril 2024 · until 31 juillet 2027

Ended
David Guyer

Chairman of the board of directors · since 26 janvier 2024 · until 30 juillet 2027

Ended
Bram Vanparys

Director · since 31 juillet 2023 · until 30 juillet 2027

Ended
Lionel Carnot

Director · since 31 juillet 2023 · until 30 juillet 2027

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Capital / shares30/06/2026
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Mandates20/05/2026
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares09/01/2026
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Capital / shares28/11/2025
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Mandates17/10/2025
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates26/09/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates16/04/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates31/07/2023
    DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-21 M €↑
  2. 2024
    Annual accounts 2024-26 M €↓
  3. 2019
    Annual accounts 2019-6,2 M €↑
  4. 2018
    Annual accounts 2018-6,3 M €↓
  5. 2017
    Annual accounts 2017-5 M €↓
  6. 2016
    Annual accounts 2016-3,1 M €↓
  7. 2015
    Annual accounts 2015-2,4 M €↓
  8. 2014
    Annual accounts 2014-908,5 k €↓
  9. 2013
    Annual accounts 2013-244,6 k €↑
  10. 2012
    Annual accounts 2012-312 k €↑
  11. 2011
    Annual accounts 2011-365,9 k €
  12. 20/07/2010
    IncorporationPublic limited company